A compact ampoule can make a large promise look simple. Numbuzin’s No.5 Glutathione TXA Advanced Dark Spot Ampoule Concentrate combines several familiar ingredient names, but a melasma reader still needs to identify the actual preparation and the evidence attached to it. The numbered range includes other serums that should not be substituted in this comparison.
Tone Notes reviewed the official US listing and help terms on October 14, 2026, alongside American Academy of Dermatology guidance. We did not order or apply the product. This article reads the formula and purchase record as a cosmetic comparison, without assigning it the status of a prescription or a proven melasma treatment.
- Format
- 10 g cosmetic ampoule
- Price observed
- $24.70; address-specific total unverified
- Percentage caveat
- 100% refers to the separate glutathione powder
- Clinical boundary
- No independently appraised melasma trial
- US returns
- No routine change-of-mind or allergy refund
The hundred-percent figure belongs to the powder
The ingredient presentation lists glutathione, tranexamic acid and niacinamide in the ampoule and separately identifies a powder component as 100% glutathione. That final figure does not describe the concentration of the entire mixed cosmetic. Assigning it to the finished preparation would make the product sound materially different from its declaration. [1]
The individual finished-formula concentrations are not established here. Our retail-serum discussion therefore treats the ingredient names as a starting point for comparison. It does not infer clinical strength, prescribing equivalence or a combination regimen from their order on a cosmetic listing.
A dark-spot claim is broader than a diagnosis
The seller discusses the appearance of uneven tone and post-acne marks. Those categories cannot establish that a reader’s discoloration is melasma or that a study addressed diagnosed melasma. We have not independently appraised a full controlled trial of this exact ampoule in that population. [1]
AAD explains that diagnosis and treatment depend on the clinical assessment. The diagnosis guide helps frame that distinction before adding another product. This review gives no instructions for replacing a prescribed medicine, and an ingredient name shared with medical literature does not resolve the differences between routes and preparations. [3]
Sensory descriptions remain the manufacturer’s account
The official page warns of a sulfur-like scent associated with glutathione and describes the ampoule as lightweight. We report the warning because it may affect expectations, but we have no firsthand observation of the odor, absorption, residue or feel under other skincare. [1]
Sensitive-skin marketing also does not establish individual tolerance. AAD’s melasma self-care advice makes avoidance of irritating skincare part of the broader conversation. That general context supports asking how a new cosmetic fits an existing plan; it is not a personal determination that this particular ampoule is suitable. [4]
The small package needs a complete price comparison
The checked US page displayed $24.70 beside $26 for a 10 g package. The larger reference amount is a seller presentation, not an independently audited discount history. We did not establish how long that package would last for any individual or confirm an address-specific checkout total. [1]
The help record lists $7.95 US shipping below a $60 order threshold after discounts. Applied to a qualifying single-item order at the captured price, those figures sum to $32.65 before tax. That arithmetic illustrates shipping’s effect; it is not a completed quote or a reason to buy unnecessary products to meet a threshold. [2]
The US return conditions deserve attention before opening
The US help terms do not offer ordinary change-of-mind returns, including unopened purchases, and exclude allergy-related refund requests. Wrong or damaged shipments have a separate reporting process within thirty days of purchase with photographic evidence. These categories should remain separate from a general satisfaction trial. [2]
The same help page contains country-specific information, so a Canadian order should not be assessed using the US summary alone. We did not contact support or complete a claim. A published policy establishes the stated conditions, while actual eligibility and reimbursement depend on the particular order and applicable process.
Keep the component label with the mixed product
A photograph or saved ingredient declaration from the actual package would make a later comparison more reliable. It should show the ampoule and powder identities together, rather than preserving only the prominent percentage. Any preparation instructions belong to the manufacturer’s current package and are not reconstructed from this review.
The same record can help identify whether a future reformulation changes the comparison. A date on this article records when the public material was checked; it does not certify that every later shipment will carry an identical declaration.
Its place in a melasma comparison remains limited
The ampoule adds a documented cosmetic option to a directory that also contains prescription services and a labeled drug. It does not erase those distinctions. A useful consultation can include the exact package, existing products and the objective for adding it, without assuming every dark-spot serum serves the same role.
Our sun-protection guide addresses another part of the care discussion. The CoreAge Rx feature is paid placement and contributes no study evidence for Numbuzin. This review offers a source-based purchasing brief, without a numerical efficacy score, an invented wear test or a promise of clearance.
Sources & further reading
Provider pages establish what a brand markets. Clinical and regulatory sources establish the limits of the evidence. Each source has its own last-checked date below.
- No.5 Glutathione TXA Advanced Dark Spot Ampoule ConcentrateOfficial product or purchase record; claims and transaction performance not independently tested · Checked October 14, 2026
- Help & FAQ | numbuzinOfficial product or purchase record; claims and transaction performance not independently tested · Checked October 14, 2026
- AAD: melasma diagnosis and treatmentAAD guidance rechecked October 10, 2026. · Checked October 14, 2026
- AAD: melasma self-careAAD guidance rechecked October 10, 2026. · Checked October 14, 2026